Received Sep 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 2 | — | — |
After the 1st dose I had slight arm pain/after the 2nd dose arm pain; after the 2nd dose arm pain, wrist; fever up to 38.5 degrees; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (After the 1st dose I had slight arm pain/after the 2nd dose arm pain), ARTHRALGIA (after the 2nd dose arm pain, wrist) and PYREXIA (fever up to 38.5 degrees) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (After the 1st dose I had slight arm pain/after the 2nd dose arm pain), ARTHRALGIA (after the 2nd dose arm pain, wrist) and PYREXIA (fever up to 38.5 degrees). At the time of the report, PAIN IN EXTREMITY (After the 1st dose I had slight arm pain/after the 2nd dose arm pain), ARTHRALGIA (after the 2nd dose arm pain, wrist) and PYREXIA (fever up to 38.5 degrees) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: fever upto 38.5 degrees. No concomitant medications were reported. It was reported that the patient not found any other emails or pages where they could contact the pharmacovigilance department to report side effects. After the first dose, the patient experienced slight arm pain. After the second dose, patient had arm pain, wrist pain, and a fever up to 38.5 degrees. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 19-Aug-2021: Upon internal review on 18-Sep-2025, significant correction was performed to update case type to valid from invalid, added suspect product second dose regimen and events (fever and wrist pain). Also, It was identified that the information in cases MOD-2021-298294 and MOD-2021-298283 are pertaining to the same patient and same product. Hence, all information from the case MOD-2021-298294 was added and merged with the retained case MOD-2021-298283. The case MOD-2021-298294 will be deleted from the safety database. On 18-Dec-2023: Upon internal review on 18-Dec-2023, non-significant correction was performed to update country of incidence, reporter country, patient country, country in which event occurred for all events and suspect product was re-selected (drug authorization country and obtain drug country updated).
Test Name: Temperature; Result Unstructured Data: fever upto 38.5 degrees